- ASCO® 2024
- Yale Cancer Answers
- ASH CME Series
- Smilow Shares with Primary Care
- Grand Rounds
- Head and Neck
- Gynecologic
- Benign Hematology
- Breast
- GI
- Lung
- GU
- Hematologic Oncology
- Brain
- Cancer Screening
- DEI (Diversity, Equity and Inclusion)
- 2021 ASH Highlights
- General Events
- Events
Playback speed
10 seconds
Advances in Targeted Therapy for NSCLC: What Is the Importance of Biopsies in Identifying Acquired Resistance Mutations at Progression? How to Determine Who Will Benefit From Oral TKIs?
By
Yale Cancer Center
FEATURING
Anne Chiang
By
Yale Cancer Center
FEATURING
Anne Chiang
266 views
December 8, 2020
Comments 0
Login to view comments.
Click here to Login
Lung